Overview of current venous thromboembolism protocols in hip reconstruction.
Venous thromboembolic disease continues to be a serious complication of total-hip arthroplasty. The use of anticoagulant drugs for preventing this complication has repeatedly been proven to be useful. This article reviews the current evidence-based recommendations for anticoagulant prophylaxis after total-hip arthroplasty and provides insight into the current areas of active research and controversy.
Lazo-Langner
Alejandro
A
Department of Medicine, University of Western Ontario, 800 Commissioners Road, E PO Box 5010 Room A2-401, London, ON N6A 5W9, Canada.
Rodger
Marc A
MA
D000925:Anticoagulants / Q000627:therapeutic use; D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects*; D002985:Clinical Protocols; D006760:Hospitalization; D006801:Humans; D010351:Patient Discharge; D012307:Risk Factors; D054556:Venous Thromboembolism / Q000209:etiology* / Q000517:prevention & control*
D000925:Anticoagulants